16 September 2019 : Laboratory Research
PAS Domain Containing Repressor 1 (PASD1) Promotes Glioma Cell Proliferation Through Inhibiting Apoptosis In VitroRuoyan Li1BCDEF, Mengguo Guo1BCDEF, Laijun Song1AG*
Med Sci Monit 2019; 25:6955-6964
BACKGROUND: PAS domain containing repressor 1 (PASD1), the cancer-testis antigen (CTA), has been reported to be aberrantly expressed in various cancer tissues and cancer cell lines; however, normal PASD1 expression can be detected in normal tissue, excluding testicular tissue. Moreover, PASD1 is reported to be abnormally expressed in various malignant tumors. However, it remains unclear whether PASD1 participates in tumorigenesis of glioma.
MATERIAL AND METHODS: PASD1 expression was detected by immunohistochemistry in 155 glioma tissue specimens in this study. Furthermore, the relationship of PASD1 expression with clinicopathological features in glioma cases was statistically analyzed. In addition, PASD1 was knocked down by small interference RNA (shRNA) in glioma cell line (LN229), so as to assess the potential to use it as the target for treating glioma.
RESULTS: Our findings suggested that PASD1 expression in glioma patients was extremely upregulated compared with that in normal tissue samples and cell lines. Moreover, PASD1 expression was found to be markedly correlated with gender, The World Health Organization grade and p53 expression; in addition, high PASD1 expression indicated poor prognosis for glioma patients. Additionally, downregulation of PASD1 inhibited the proliferation ability of cells and resulted in cell arrest at the G2/M phase, which was achieved through accelerating apoptosis. Furthermore, our results indicated that PASD1 downregulation could upregulate some apoptosis-modulating proteins at the same time it downregulated some cycle-regulating proteins.
CONCLUSIONS: Taken together, our findings demonstrated that PASD1, an oncogene, can potentially serve as an independent prognostic factor for glioma patients.
Keywords: Cell Cycle, Glioma, Aged, Antigens, Neoplasm, Antigens, Nuclear, carcinogenesis, Cell Death, Immunohistochemistry, Middle Aged, Prognosis, Sex Factors, transcriptome
01 September 2023 : EditorialEditorial: A Rapid Global Increase in COVID-19 is Due to the Emergence of the EG.5 (Eris) Subvariant of Omicron SARS-CoV-2
Med Sci Monit 2023; 29:e942244
22 Sep 2023 : Clinical ResearchComparative Analysis of Symptomatology in Hospitalized Children with RSV, COVID-19, and Influenza Infections
Med Sci Monit In Press; DOI: 10.12659/MSM.941229
21 Sep 2023 : Clinical ResearchThe Impact of Implementing the Vortex Approach on Airway Management Performance in Stressed Medical Student...
Med Sci Monit In Press; DOI: 10.12659/MSM.940372
20 Sep 2023 : Clinical ResearchChanges in Upper Airway Anatomy Following Orthodontic Treatment for Malocclusion: A Comparative Retrospecti...
Med Sci Monit In Press; DOI: 10.12659/MSM.941749
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292